- UBA6 (Ubiquitin-like modifier-activating enzyme 6) is a gene that encodes an E1 ubiquitin-activating enzyme involved in the ubiquitin–proteasome system (UPS).
- The UPS is a fundamental cellular pathway that regulates protein homeostasis by tagging proteins with ubiquitin molecules, marking them for degradation, recycling, or functional modification. While the closely related UBA1 enzyme is considered the primary ubiquitin-activating enzyme in most cells, UBA6 provides an alternative and specialized ubiquitin activation pathway, broadening the versatility and selectivity of protein regulation.
- UBA6 is unusual among E1 enzymes because it can activate not only ubiquitin but also a ubiquitin-like protein called FAT10 (HLA-F adjacent transcript 10). This dual specificity allows UBA6 to participate in both classical ubiquitination and FAT10ylation, processes that regulate protein stability, immune responses, and cellular stress adaptation. Through these functions, UBA6 plays essential roles in cellular signaling, apoptosis, embryonic development, and stress-induced protein quality control.
- Research has shown that UBA6 activity is critical for normal development and physiology. In animal models, loss of UBA6 function leads to defects in embryogenesis, cell differentiation, and neuronal development, underscoring its importance in tightly controlled biological processes. In humans, UBA6 variants have been linked to neurodevelopmental disorders, including global developmental delay, autism spectrum disorder, seizures, and intellectual disability. These phenotypes are thought to result from impaired ubiquitin signaling in neurons, leading to abnormal synaptic development and dysregulated protein turnover in the central nervous system.
- Beyond neurodevelopment, UBA6 has been implicated in immune regulation and cancer biology. Through FAT10 conjugation, UBA6 influences immune-related protein degradation pathways, including those involved in inflammation and antigen presentation. Dysregulated UBA6 activity may alter immune cell function and contribute to pathological inflammation. Additionally, UBA6 expression changes have been observed in certain cancers, where abnormal protein degradation can promote tumor progression by stabilizing oncogenic proteins or destabilizing tumor suppressors.
- At the molecular level, UBA6 initiates the first step of ubiquitination by activating ubiquitin in an ATP-dependent manner and transferring it to an E2 conjugating enzyme, specifically USE1 (UBA6-specific E2 enzyme). This restricted E2 pairing provides a selective pathway distinct from the broader UBA1 system. The UBA6–USE1 axis, therefore, regulates a unique subset of proteins, making it an attractive target for research into selective ubiquitination processes.
- In summary, UBA6 is a specialized ubiquitin-activating enzyme with dual activity for ubiquitin and FAT10, contributing to protein quality control, immune regulation, neuronal development, and disease pathogenesis. Disruption of its function can cause neurodevelopmental syndromes in humans and has potential implications in cancer and inflammatory diseases. Because of its restricted E2 partnerships and distinct substrate repertoire, UBA6 represents not only a crucial player in fundamental biology but also a potential therapeutic target for conditions involving protein homeostasis dysfunction.
Reliability Index *****
Note: If you notice any errors or inconsistencies, we welcome your feedback. Please share your observations in the comment box below — your input helps us improve.
Highest reliability: *****
Lowest reliability: *****
